Theralase Technologies Inc
TSXV:TLTView on OTCQB

  • LAST PRICE
    0.2850
  • TODAY'S CHANGE (%)
    -0.0100 (-3.3898%)
  • Bid / Lots
    0.2800/ 58
  • Ask / Lots
    0.2850/ 10
  • Open / Previous Close
    0.2950 / 0.2950
  • Day Range
    0.2850
    0.2950
  • 52 Week Range
    0.1400
    0.3800
  • Volume
    39,300

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 15, 2024

      Show headlines and story abstract

    • 7:02AM ET on Friday Nov 15, 2024 by Dow Jones
      Companies Mentioned: TLT

      TORONTO, ON / ACCESSWIRE / November 15, 2024 / Theralase(R) Technologies Inc. ("Theralase(R)" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it has successfully closed a non-brokered private placement offering ("Offering") of units ("Units").

  • Nov 12, 2024

      Show headlines and story abstract

    • 6:31PM ET on Tuesday Nov 12, 2024 by Dow Jones
      Companies Mentioned: TLT

      TORONTO, ON / ACCESSWIRE / November 12, 2024 / Theralase(R) Technologies Inc. ("Theralase(R) " or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company proposes to extend the expiry date of 1,000,000 share purchase warrants ("Warrants") from November 17, 2024 to November 17, 2027.

Peers Headlines